Mydecine Innovations Group Inc. (CSE:MYCO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
+0.0050 (100.00%)
Aug 13, 2025, 4:00 PM EDT
-33.33%
Market Cap 229.37K
Revenue (ttm) n/a
Net Income (ttm) 220.73K
Shares Out n/a
EPS (ttm) 0.00
PE Ratio 1.04
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,388
Average Volume 31,617
Open 0.0100
Previous Close 0.0050
Day's Range 0.0100 - 0.0100
52-Week Range 0.0050 - 0.0150
Beta 2.36
RSI 60.16
Earnings Date Aug 20, 2025

About CSE:MYCO

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations... [Read more]

Sector Healthcare
Founded 2013
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.